Japanese Society for Cancer of the Colon and Rectum (JS']JSCCR) guidelines 2016 for the treatment of colorectal cancer

被引：690

作者：

Watanabe, Toshiaki ^{[1
]}

Muro, Kei ^{[2
]}

Ajioka, Yoichi ^{[3
]}

Hashiguchi, Yojiro ^{[4
]}

Ito, Yoshinori ^{[5
]}

Saito, Yutaka ^{[6
]}

Hamaguchi, Tetsuya ^{[7
]}

Ishida, Hideyuki ^{[8
]}

Ishiguro, Megumi ^{[9
]}

Ishihara, Soichiro ^{[1
]}

Kanemitsu, Yukihide ^{[10
]}

Kawano, Hiroshi ^{[11
]}

Kinugasa, Yusuke ^{[12
]}

Kokudo, Norihiro ^{[13
]}

Murofushi, Keiko ^{[14
]}

Nakajima, Takako ^{[15
]}

Oka, Shiro ^{[16
]}

Sakai, Yoshiharu ^{[17
]}

Tsuji, Akihito ^{[18
]}

Uehara, Keisuke ^{[19
]}

Ueno, Hideki ^{[20
]}

Yamazaki, Kentaro ^{[21
]}

Yoshida, Masahiro ^{[22
]}

Yoshino, Takayuki ^{[23
]}

Boku, Narikazu ^{[7
]}

Fujimori, Takahiro ^{[24
]}

Itabashi, Michio ^{[25
]}

Koinuma, Nobuo ^{[26
]}

Morita, Takayuki ^{[27
]}

Nishimura, Genichi ^{[28
]}

Sakata, Yuh ^{[29
]}

Shimada, Yasuhiro ^{[30
]}

Takahashi, Keiichi ^{[31
]}

Tanaka, Shinji ^{[32
]}

Tsuruta, Osamu ^{[33
]}

Yamaguchi, Toshiharu ^{[34
]}

Yamaguchi, Naohiko ^{[35
]}

Tanaka, Toshiaki ^{[1
]}

Kotake, Kenjiro ^{[36
]}

Sugihara, Kenichi ^{[37
]}

机构：

[1] Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan

[2] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan

[3] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol & Diagnost Pathol, Niigata, Japan

[4] Teikyo Univ, Dept Surg, Tokyo, Japan

[5] Natl Canc Ctr, Dept Radiat Oncol, Tokyo, Japan

[6] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan

[7] Natl Canc Ctr, Div Gastrointestinal Med Oncol, Tokyo, Japan

[8] Saitama Med Univ, Dept Digest Tract & Gen Surg, Saitama Med Ctr, Saitama, Japan

[9] Tokyo Med & Dent Univ, Dept Translat Oncol, Grad Sch, Tokyo, Japan

[10] Natl Canc Ctr, Colorectal Surg Div, Tokyo, Japan

[11] St Marys Hosp, Dept Gastroenterol, Fukuoka, Japan

[12] Shizuoka Canc Ctr, Dept Colon & Rectal Surg, Shizuoka, Japan

[13] Univ Tokyo, Grad Sch Med, Hepatobiliary Pancreat Surg Div, Artificial Organ & Transplantat Div,Dept Surg, Tokyo, Japan

[14] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Radiat Oncol, Tokyo, Japan

[15] St Marianna Univ, Dept Clin Oncol, Sch Med, Kawasaki, Kanagawa, Japan

[16] Hiroshima Univ Hosp, Gastroenterol & Metab, Hiroshima, Japan

[17] Kyoto Univ, Dept Surg, Kyoto, Japan

[18] Kagawa Univ, Dept Clin Oncol, Fac Med, Takamatsu, Kagawa, Japan

[19] Nagoya Univ, Div Surg Oncol, Dept Surg, Grad Sch Med, Nagoya, Aichi, Japan

[20] Natl Def Med Coll, Dept Surg, Saitama, Japan

[21] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan

[22] Int Univ Hlth & Welf, Chemotherapy Res Inst, Dept Hemodialysis & Surg, Ichikawa, Japan

[23] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan

[24] Shinko Hosp, Diagnost Pathol Ctr, Kobe, Hyogo, Japan

[25] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Tokyo, Japan

[26] Tohoku Med & Pharmaceut Univ, Dept Hlth Adm & Policy, Sendai, Miyagi, Japan

[27] Aomori Prefectural Cent Hosp, Dept Surg, Ctr Canc, Aomori, Japan

[28] Japanese Red Cross Kanazawa Hosp, Dept Surg, Kanazawa, Ishikawa, Japan

[29] Misawa City Hosp, CEO, Misawa, Japan

[30] Kochi Hlth Sci Ctr, Div Clin Oncolgy, Kochi, Japan

[31] Komagome Hosp, Dept Surg, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan

[32] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan

[33] Kurume Univ, Div GI Endoscopy, Sch Med, Fukuoka, Japan

[34] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan

[35] Lib SEIREI SAKURA Citizen Hosp, Sakura, Chiba, Japan

[36] Tochigi Canc Ctr, Dept Surg, Utsunomiya, Tochigi, Japan

[37] Koujinkai Daiichi Hosp, Tokyo, Japan

来源：

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 23卷 / 01期

关键词：

Colorectal cancer; Guideline; Surgery; Chemotherapy; Endoscopy; Radiotherapy; PHASE-III TRIAL; TOTAL MESORECTAL EXCISION; FLUOROURACIL PLUS LEUCOVORIN; INTERVAL HEPATIC RESECTION; SINGLE-AGENT PANITUMUMAB; FRAIL ELDERLY-PATIENTS; LYMPH-NODE METASTASIS; HIGH-DOSE LEUCOVORIN; INTENSIVE FOLLOW-UP; WILD-TYPE KRAS;

D O I：

10.1007/s10147-017-1101-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Japanese mortality due to colorectal cancer is on the rise, surpassing 49,000 in 2015. Many new treatment methods have been developed during recent decades. The Japanese Society for Cancer of the Colon and Rectum Guidelines 2016 for the treatment of colorectal cancer (JSCCR Guidelines 2016) were prepared to show standard treatment strategies for colorectal cancer, to eliminate disparities among institutions in terms of treatment, to eliminate unnecessary treatment and insufficient treatment, and to deepen mutual understanding between health-care professionals and patients by making these Guidelines available to the general public. These Guidelines were prepared by consensus reached by the JSCCR Guideline Committee, based on a careful review of the evidence retrieved by literature searches, and in view of the medical health insurance system and actual clinical practice settings in Japan. Therefore, these Guidelines can be used as a tool for treating colorectal cancer in actual clinical practice settings. More specifically, they can be used as a guide to obtaining informed consent from patients and choosing the method of treatment for each patient. As a result of the discussions held by the Guideline Committee, controversial issues were selected as Clinical Questions, and recommendations were made. Each recommendation is accompanied by a classification of the evidence and a classification of recommendation categories based on the consensus reached by the Guideline Committee members. Here we present the English version of the JSCCR Guidelines 2016.

引用

页码：1 / 34

页数：34

共 147 条

[71] Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
Hofheinz, Ralf-Dieter
Wenz, Frederik
Post, Stefan
Matzdorff, Axel
Laechelt, Stephan
Hartmann, Joerg T.
Mueller, Lothar
Link, Hartmut
Moehler, Markus
Kettner, Erika
Fritz, Elisabeth
Hieber, Udo
Lindemann, Hans Walter
Grunewald, Martina
Kremers, Stephan
Constantin, Christian
Hipp, Matthias
Hartung, Gernot
Gencer, Deniz
Kienle, Peter
Burkholder, Iris
Hochhaus, Andreas
[J]. LANCET ONCOLOGY, 2012, 13 (06) : 579 - 588
[72] Hughes KS, 2000, ARCH SURG-CHICAGO, V135, P479
[73] Bevacizurnab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer
Hurwitz, HI
Fehrenbacher, L
Hainsworth, JD
Heim, W
Berlin, J
Holmgren, E
Hambleton, J
Novotny, WF
Kabbinavar, F
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3502 - 3508
[74] Long-term Outcomes After Resection for Submucosal Invasive Colorectal Cancers
Ikematsu, Hiroaki
Yoda, Yusuke
Matsuda, Takahisa
Yamaguchi, Yuichiro
Hotta, Kinichi
Kobayashi, Nozomu
Fujii, Takahiro
Oono, Yasuhiro
Sakamoto, Taku
Nakajima, Takeshi
Takao, Madoka
Shinohara, Tomoaki
Murakami, Yoshitaka
Fujimori, Takahiro
Kaneko, Kazuhiro
Saito, Yutaka
[J]. GASTROENTEROLOGY, 2013, 144 (03) : 551 - 559
[75] Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive
Jaeschke, Roman
Guyatt, Gordon H.
Dellinger, Phil
Schunemann, Holger
Levy, Mitchell M.
Kunz, Regina
Norris, Susan
Bion, Julian
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 (7665): : a744
[76] Japanese Society for Cancer of the Colon and Rectum, 1994, GEN RUL CLIN PATH ST
[77] Japanese Society for Cancer of the Colon and Rectum, 2016, JSCCR GUID 2012 CLIN
[78] Japanese Society for Cancer of the Colon and Rectum, 1980, GEN RUL CLIN PATH ST
[79] Japanese Society for Cancer of the Colon and Rectum, 2013, JAP CLASS COL CARC
[80] Japanese Society for Cancer of the Colon and Rectum, 2005, JSCCR GUID 2005 TREA

← 3 4 5 6 7 8 9 10 11 12 →